Last reviewed · How we verify
NCT05284578
The Effects of Expressive Writing and Compassionate Letter Writing on Emotional Distress Intolerance
NA trial testing Self-compassionate writing intervention in Distress Intolerance in 424 participants. Completed in 21 July 2022.
21 July 2022
Quick facts
| Lead sponsor | University of Waterloo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 424 |
| Start date | 4 July 2021 |
| Primary completion | 21 July 2022 |
| Estimated completion | 21 July 2022 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Self-compassionate writing intervention
- Expressive writing intervention
- Control writing task
Conditions studied
- Distress Intolerance — all drugs for Distress Intolerance →
Sponsor
University of Waterloo
Who can join
Eligibility, any sex, with Distress Intolerance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Perceived emotional distress intolerance is a transdiagnostic marker of psychopathology associated with psychological and interpersonal dysfunction, and the development of interventions for perceived emotional distress intolerance is of prime importance. One potential intervention is a behavioural experiment, i.e. a cognitive behaviour therapy technique where clients undergo an exercise designed to test a maladaptive belief, e.g., that negative emotions are unbearable, and adjust their belief to accommodate any disconfirmatory information that arises through the exercise. This study examines the effects of a one-session self-compassion writing behavioural experiment compared to a one-session expressive writing behavioural experiment on low perceived distress tolerance. Participants were recruited from the University of Waterloo and Prolific, and were randomly assigned to the self-compassion condition, expressive writing condition, or a control condition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05284578
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Waterloo trials
Trials by the same sponsor.
- NCT07505407 — CHOICE+ Quality Improvement for Long Term Care Homes · enrolling by invitation
- NCT07341763 — Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment · NA · not yet recruiting
- NCT07451184 — Comparison of Ocular Lubricants in People With Symptoms of Dry Eye · Phase 4 · recruiting
- NCT07288684 — Chiropractor Delivered Virtual Intervention After Vertebral frActure · NA · recruiting
- NCT06966349 — Quantifying Ocular Surface Aberrations After Tear Film Interventions · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05284578 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Waterloo
- Last refreshed: 4 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05284578.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing